Somatostatin receptor scintigraphy - The definitive technique for characterizing vasoactive intestinal peptide-secreting tumors

被引：9
作者：
Thomason, JWW
Martin, RS
Fincher, ME
机构：
[1] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA
[2] Med Coll Georgia, Dept Radiol, Augusta, GA 30912 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2000年 / 25卷 / 09期
关键词：
octreotide; somatostatin receptor scintigraphy; vasoactive intestinal peptide-secreting tumor; (VIPoma); watery diarrhea; hypokalemia; and achlorhydria; (WDHA) syndrome;
D O I：
10.1097/00003072-200009000-00001
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Vasoactive intestinal peptide-secreting tumors (VIPo-mas) are extremely rare and difficult to diagnose, The authors describe a patient who was found to have a VIPoma after 3 years of symptoms. Somatostatin receptor scintigraphy using indium-labeled octreotide localized her tumor and prompted a surgical resection, This is the preferred imaging study for the earliest, most accurate, and cost-effective identification of VIPomas and their metastases.
引用
收藏
页码：661 / 664
页数：4
相关论文
共 20 条
12